Assessment of the Functionality and Performance of an Endotracheal (ET) Tube Protection Device
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Respiratory Insufficiency
- 发起方
- Hollister Incorporated
- 入组人数
- 65
- 试验地点
- 5
- 主要终点
- Prevention of Damage and/or Occlusion of Endotracheal (ET) Tube During Use
- 状态
- 已完成
- 最后更新
- 10年前
概览
简要总结
Endotracheal intubation is the translaryngeal placement of a tube into the trachea via the nose or mouth. Endotracheal tubes must be securely fixed to prevent movement, which may result in accidental slippage of the tube into a mainstream bronchus or into the pharynx. Hollister Incorporated is assessing the functionality and performance of an endotracheal tube securement device.
详细描述
This was a multiple site assessment of the Anchor Fast with enhanced tube protection. Subjects already intubated who required a change of tube-securing device or subjects requiring intubation for greater than 24 hours who meet the inclusion and exclusion criteria were eligible to enroll into the study.The study was open to adult subjects without an existing neck injury who required oral tracheal intubation for greater than 24 hours. Subjects were required to have intact skin on the application site and to be free of facial hair, damaged skin or conditions on the application site (e.g. sunburn, scars, moles or other disfigurations), and significant skin diseases on the application site (e.g. psoriasis, eczema, atopic dermatitis, active cancer) which may have contraindicated participation.
研究者
入排标准
入选标准
- •Is 18 years of age or older; male or female and requiring oral tracheal intubation.
- •Has intact skin on application site.
- •Willingly signs or their authorized representative willingly signs the Informed Consent.
- •Is qualified to participate in the opinion of the Investigator.
排除标准
- •Has an existing neck injury.
- •Has protruding upper teeth, without teeth or is unable to wear upper dentures.
- •Has facial hair.
- •Has clinically significant skin diseases on the application site which may contraindicate participation, including psoriasis, eczema, atopic dermatitis, active cancer.
- •Has damaged skin or conditions on the application site which includes sunburn, scars, moles or other disfiguration of the test site.
- •Has a known or stated allergy to adhesive bandages, or any of the product types being tested.
- •Uses of topical drugs on the application site.
- •Uses lotions, creams or oils on the application site.
- •Currently is participating in any clinical testing which may affect performance of this device.
- •Has been previously intubated with skin irritation or pressure sores surrounding the mouth.
结局指标
主要结局
Prevention of Damage and/or Occlusion of Endotracheal (ET) Tube During Use
时间窗: 14 days
Number of participants with damage of ET tube and Number of participants with occlusion of ET tube
次要结局
- Ease of Use(Between 1 - 14 days)